These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 2484710

  • 1. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances.
    Berenger-Bahuet FP, Rolland PH.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S98-105. PubMed ID: 2484710
    [Abstract] [Full Text] [Related]

  • 2. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM, Topf HG, Trusen B, Rauh M, Rascher W, Dötsch J.
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [Abstract] [Full Text] [Related]

  • 3. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
    Bassenge E.
    Z Kardiol; 1991 Jul; 80 Suppl 5():17-21. PubMed ID: 1776330
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E, Lähteenmäki TA, Alanko J, Vuorinen P, Vapaatalo H.
    Arzneimittelforschung; 1997 Oct 01; 47(10):1093-8. PubMed ID: 9368700
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
    Gerzer R, Drummer C, Karrenbrock B, Heim JM.
    J Cardiovasc Pharmacol; 1989 Oct 01; 14 Suppl 11():S115-9. PubMed ID: 2484688
    [Abstract] [Full Text] [Related]

  • 7. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells.
    Minuz P, Lechi C, Gaino S, Bonapace S, Fontana L, Garbin U, Paluani F, Cominacini L, Zatti M, Lechi A.
    Thromb Haemost; 1995 Oct 01; 74(4):1175-9. PubMed ID: 8560431
    [Abstract] [Full Text] [Related]

  • 8. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H, Fret HR, Herman AG.
    J Cardiovasc Pharmacol; 1989 Oct 01; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [Abstract] [Full Text] [Related]

  • 9. [Antiplatelet properties of nitrogen monoxide].
    Adrie C.
    Arch Mal Coeur Vaiss; 1996 Nov 01; 89(11 Suppl):1527-32. PubMed ID: 9092414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of SIN 1 on the interactions of endothelial cells and thrombocytes].
    Kirchmaier CM, Altorjay I, Bellinger O, Breddin HK.
    Z Kardiol; 1991 Nov 01; 80 Suppl 5():13-6. PubMed ID: 1776329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular endothelial cells synthesize nitric oxide from L-arginine.
    Palmer RM, Ashton DS, Moncada S.
    Nature; 1988 Jun 16; 333(6174):664-6. PubMed ID: 3131684
    [Abstract] [Full Text] [Related]

  • 14. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A, Dunk C, Kniss D, Wilkes M.
    Lab Invest; 1997 Jun 16; 76(6):779-91. PubMed ID: 9194854
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, Radomski MW.
    Cancer Res; 2001 Jan 01; 61(1):376-82. PubMed ID: 11196190
    [Abstract] [Full Text] [Related]

  • 16. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
    Bassenge E.
    Eur Heart J; 1991 Nov 01; 12 Suppl E():12-5. PubMed ID: 1665128
    [Abstract] [Full Text] [Related]

  • 17. [Endothelium-derived relaxing factor(s): endogenous nitrates in the circulation?].
    Lüscher TF, Yang Z, Diederich D, Schneider K, von Segesser L, Siebenmann R, Stulz P, Bühler FR.
    Schweiz Med Wochenschr; 1988 Nov 19; 118(46):1724-9. PubMed ID: 3062771
    [Abstract] [Full Text] [Related]

  • 18. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty.
    Groves PH, Banning AP, Penny WJ, Newby AC, Cheadle HA, Lewis MJ.
    Cardiovasc Res; 1995 Jul 19; 30(1):87-96. PubMed ID: 7553728
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK.
    Platelets; 2003 Jul 19; 14(7-8):421-7. PubMed ID: 14713511
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide derived from endothelial cells inhibits Na+/H+ exchange in rabbit platelets activated by thrombin.
    Chen H, Guo ZG.
    Zhongguo Yao Li Xue Bao; 1999 Apr 19; 20(4):333-7. PubMed ID: 10452119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.